Not yet a member?
Print This Post
view / write comments
Dr. Khuri discusses EGFR-based adv #NSCLC trials: no good reason to add chemo w/EGFR TKI, at least not in someone w/o EGFR mut’n. #ASCO10
Related posts:
Related posts brought to you by Yet Another Related Posts Plugin.
Posted in: Tweets email to a friend
Print This Post
No Comments
Login (Must Be Logged In To Comment)